Medicinal – Page 114

Emerging Infections Network Survey of Screening for Cryptococcal Antigenemia, United States, 2024

mycolabadmin

Researchers surveyed infectious disease doctors across the United States about how often they screen HIV patients for cryptococcal infections using a simple blood test. They found that only about one-third to two-thirds of doctors regularly perform this screening despite guidelines recommending it. Many doctors expressed uncertainty about whether the screening is beneficial or weren’t sure about the official recommendations, suggesting a need for better education about this potentially life-saving test.

Genomic Insights of Candida krusei, an Emerging Fungal Pathogen With Intrinsic Antifungal Resistance

mycolabadmin

Candida krusei is a yeast that causes serious bloodstream infections, particularly in people with weakened immune systems. Unlike many other fungi, it naturally resists common antifungal drugs like fluconazole, making infections hard to treat. The organism can form protective biofilms and has multiple genetic mechanisms that help it survive antifungal treatment. Researchers are exploring new drugs and treatment strategies to combat this growing health threat, especially in hospitals.

Updated Taxonomy of Chinese Craterellus (Hydnaceae, Cantharellales) with Three New Species Described

mycolabadmin

Scientists have discovered and described three new species of trumpet mushrooms (Craterellus) found in China. These mushrooms are valuable because they form helpful relationships with trees and have medicinal properties. By studying both the physical characteristics and DNA of 109 mushroom samples, researchers identified seventeen different Craterellus species in China, greatly expanding our understanding of this important group of edible fungi.

Isavuconazonium Utilization in Pediatric Patients at a Free-Standing Children’s Hospital

mycolabadmin

Researchers at Children’s Hospital Los Angeles studied how well a newer antifungal medication called isavuconazonium works in children with cancer and blood disorders who are at high risk for serious fungal infections. The medication was recently approved for use in children ages 1 and older. The study found that the medication was generally safe and effective, though doctors need to monitor liver function and drug levels to ensure proper dosing and catch any side effects early.

Production of fungal hypocrellin photosensitizers: Exploiting bambusicolous fungi and elicitation strategies in mycelium cultures

mycolabadmin

Hypocrellins are powerful compounds from fungi that can treat cancers and infections through light-activated therapy. Since wild sources are limited, scientists are growing these fungi in laboratory cultures and using special techniques to boost production. This review summarizes the best methods for producing hypocrellins, from choosing the right fungal strains to optimizing growing conditions and using natural stimulants to increase yields.

Photo Quiz: Asteroid bodies in a skin biopsy of a farmer

mycolabadmin

A farmer developed nodular skin lesions two weeks after a wrist injury during farming activities, which turned out to be sporotrichosis, a fungal infection caused by Sporothrix globosa. Skin biopsy revealed characteristic structures called asteroid bodies that helped suggest the diagnosis. The infection was confirmed through fungal culture and DNA testing, and was successfully treated with potassium iodide over six months.

Cinchona-based liquid formulation exhibits antifungal activity through Tryptophan starvation and disruption of mitochondrial respiration in Rhizoctonia Solani

mycolabadmin

Scientists discovered that a liquid extract from Cinchona bark, which contains quinine, can effectively kill a fungus that damages rice crops. The treatment works by blocking the fungus’s ability to absorb tryptophan (an important amino acid) and damaging its energy-producing mitochondria. When tryptophan was added back to the treatment, the fungus recovered, confirming this is the main way the extract works. This natural, plant-based approach could provide an eco-friendly alternative to chemical fungicides while reducing the risk of the fungus developing resistance.

Localization of Secondary Metabolites in Relict Gymnosperms of the Genus Sequoia In Vivo and in Cell Cultures In Vitro, and the Biological Activity of Their Extracts

mycolabadmin

Researchers studied an ancient giant redwood tree species to extract valuable medicinal compounds. They successfully grew Sequoia cells in laboratory culture that produced powerful cancer-fighting and antifungal substances. These extracts showed promise against cervical cancer and brain tumor cells while being safe to normal cells, offering a sustainable way to harvest these compounds without damaging wild redwood populations.

Identification of Filamentous Fungi: An Evaluation of Three MALDI-TOF Mass Spectrometry Systems

mycolabadmin

This study compared three laboratory machines that identify fungi using a technique called MALDI-TOF mass spectrometry. Researchers tested 77 different fungal samples on each machine to see which one worked best. All three machines were useful for routine lab work, but they each worked best at different time points after the fungi started growing. The study shows that labs should be aware of when to test their samples for the most accurate results.

Ascosphaera apis as a target for the antifungal activity of symbiotic Bifidobacteria in honey bees

mycolabadmin

Researchers found that certain beneficial bacteria (Bifidobacterium asteroides) living in honey bee guts can fight the fungus that causes chalkbrood disease, a serious condition affecting bee colonies. These bacteria produce natural compounds, especially propanoic acid and ethanol, that kill the fungus and prevent it from growing. This discovery offers a safe, natural alternative to chemical treatments for protecting honeybees from fungal infections while maintaining colony health.

Research Topic: Medicinal